Transcription factor YY1: Structure, function, and therapeutic implications in cancer biology

Oncogene

Volumn 25, Issue 8, 2006, Pages 1125-1142

  Gordon, S ^a   Akopyan, G ^a   Garban, H ^a,b   Bonavida, B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apoptosis; Cell cycle; DNA binding proteins; Epigenetic regulation; Gene expression regulation; Transcription activation; Transcription suppression

Indexed keywords

CYTOKINE; CYTOPLASM PROTEIN; DNA; GENE PRODUCT; HISTONE DEACETYLASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN P53; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR YY1; TUMOR MARKER;

APOPTOSIS; BASAL CELL CARCINOMA; BINDING SITE; BIOLOGY; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE PROGRESSION; CELL DEATH; CELL PROLIFERATION; CRYSTAL STRUCTURE; DIAGNOSTIC VALUE; DNA CONFORMATION; DOWN REGULATION; EMBRYO DEVELOPMENT; ENDOCRINE TUMOR; EPITHELIUM TUMOR; GENE EXPRESSION REGULATION; GENETIC REGULATION; GENETIC TRANSCRIPTION; GENOTOXICITY; HEMATOPOIETIC SYSTEM TUMOR; HUMAN; IMMUNITY; LIVER CELL CARCINOMA; METASTASIS POTENTIAL; MOLECULAR MECHANICS; ONCOGENE C MYC; PRIORITY JOURNAL; PROGNOSIS; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TARGETING; REGULATORY MECHANISM; REVIEW; SEQUENCE HOMOLOGY; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; TUMOR RESISTANCE;

ANIMALS; BASE SEQUENCE; HUMANS; MEDICAL ONCOLOGY; MOLECULAR SEQUENCE DATA; NEOPLASMS; YY1 TRANSCRIPTION FACTOR;

EID: 33644507479     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1209080     Document Type: Review

References (95)

1. Amati B, Alevizopoulos K, Vlach J. (1998). Front Biosci 15: d250-d268.
2. Austen M, Cerni C, Luscher-Firzlaff JM, Luscher B. (1998). Oncogene 17: 511-520.
3. Bartek J, Lukas J. (2001). FEBS Lett 490: 117-122.
4. Beier UH, Gorogh T. (2005). Int J Cancer 115: 6-10.
5. Berns KI, Bohenzky RA. (1987). Adv Virus Res 32: 243-306.
6. Brankin B, Skaar TC, Brotzman M, Trock B, Clarke R. (1998). Cancer Epidemiol Biomarkers Prev 7: 1109-1115.
7. Chan YJ, Chiou CJ, Huang Q, Hayward GS. (1996). J Virol 70: 8590-8605.
8. Chang LS, Shi Y, Shenk T. (1989). J Virol 63: 3479-3488.
9. Chen RF, Li ZH, Kong XH, Chen JS. (2005). World J Gastroenterol 11: 726-728.
10. Chen S, Mills L, Perry P, Riddle S, Wobig R, Lown R et al. (1992). J Virol 66: 4304-4314.
11. Chiang CM, Roeder RG. (1995). Science 267: 531-536.
12. Cicatiello L, Addeo R, Sasso A, Altucci L, Petrizzi VB, Borgo R et al. (2004). Mol Cell Biol 24: 7260-7274.
13. Dong XP, Stubenrauch F, Beyer-Finkler E, Pfister H. (1994). Int J Cancer 58: 803-808.
14. Donohoe ME, Zhang X, McGinnis L, Biggers J, Li E, Shi Y. (1999). Mol Cell Biol 19: 7237-7244.
15. Evan GI, Vousden KH. (2001). Nature 411: 342-348.
16. Flanagan JR, Becker KG, Ennist DL, Gleason SL, Driggers PH, Levi BZ et al. (1992). Mol Cell Biol 12: 38-44.
17. Fridman JS, Lowe SW. (2003). Oncogene 22: 9030-9040.
18. Galvin KM, Shi Y. (1997). Mol Cell Biol 17: 3723-3732.
19. Garban HJ, Bonavida B. (2001). J Immunol 167: 75-81.
20. Gronroos E, Terentiev AA, Punga T, Ericsson J. (2004). Proc Natl Acad Sci USA 101: 12165-12170.
21. Guo B, Odgren PR, van Wijnen AJ, Last TJ, Nickerson J, Penman S et al. (1995). Proc Natl Acad Sci USA 92: 10526-10530.
22. Guo B, Stein JL, van Wijnen AJ, Stein GS. (1997). Biochemistry 36: 14447-14455.
23. Hariharan N, Kelley DE, Perry RP. (1991). Proc Natl Acad Sci USA 88: 9799-9803.
24. He G, Margolis DM. (2002). Mol Cell Biol 22: 2965-2973.
25. Hilbi H, Chen Y, Thirumalai K, Zychlinsky A. (1997). Infect Immun 65: 5165-5170.
26. Hiromura M, Choi CH, Sabourin NA, Jones H, Bachvarov D, Usheva A. (2003). J Biol Chem 278: 14046-14052.
27. Hongo F, Garban H, Huerta-Yepez S, Vega M, Jazirehi A, Mizutani Y et al. (2004). Proceedings of the AACR. Washington, DC, Vol. 45.
28. Houbaviy HB, Usheva A, Shenk T, Burley SK. (1996). Proc Natl Acad Sci USA 93: 13577-13582.
29. Huang NE, Lin CH, Lin YS, Yu WC. (2003). Biochem Biophys Res Commun 306: 267-275.
30. Huber MA, Azoitei N, Baumann B, Grunert S, Sommer A, Pehamberger H et al. (2004). J Clin Invest 114: 569-581.
31. Huerta-Yepez S, Vega M, Escoto-Chavez SE, Murdock B, Sakai T, Bonavida B. (2005). Proceedings of the AACR. Anaheim, CA, Vol. 46.
32. Huerta-Yepez S, Vega M, Jazirehi A, Garban H, Hongo F, Cheng G et al. (2004). Oncogene 23: 4993-5003.
33. Jazirehi AR, Huerta-Yepez S, Cheng G, Bonavida B. (2005). Cancer Res 65: 264-276.
34. Kano A, Watanabe Y, Takeda N, Aizawa S, Akaike T. (1997). J Biochem (Tokyo) 121: 677-683.
35. Kappes F, Damoc C, Knippers R, Przybylski M, Pinna LA, Gruss C. (2004). Mol Cell Biol 24: 6011-6020.
36. Karantzoulis-Fegaras F, Antoniou H, Lai SL, Kulkarni G, D'Abreo C, Wong GK et al. (1999). J Biol Chem 274: 3076-3093.
37. Kim J, Shapiro DJ. (1996). Nucleic Acids Res 24: 4341-4348.
38. Kurisaki K, Kurisaki A, Valcourt U, Terentiev AA, Pardali K, Ten Dijke P et al. (2003). Mol Cell Biol 23: 4494-4510.
39. Laster SM, Wood JG, Gooding LR. (1988). J Immunol 141: 2629-2634.
40. Lee HY, Chaudhary J, Walsh GL, Hong WK, Kurie JM. (1998). Oncogene 16: 3039-3046.
41. Lee JS, Galvin KM, See RH, Eckner R, Livingston D, Moran E et al. (1995). Genes Dev 9: 1188-1198.
42. Lee KH, Evans S, Ruan TY, Lassar AB. (2004). Development 131: 4709-4723.
43. Lee TC, Shi Y, Schwartz RJ. (1992). Proc Natl Acad Sci USA 89: 9814-9818.
44. Li CQ, Robles AI, Hanigan CL, Hofseth LJ, Trudel LJ, Harris CC et al. (2004). Cancer Res 64: 3022-3029.
45. Lichy JH, Majidi M, Elbaum J, Tsai MM. (1996). Nucleic Acids Res 24: 4700-4708.
46. Lu SY, Rodriguez M, Liao WS. (1994). Mol Cell Biol 14: 6253-6263.
47. Luo JL, Maeda S, Hsu LC, Yagita H, Karin M. (2004). Cancer Cell 6: 297-305.
48. Martelli F, Iacobini C, Caruso M, Felsani A. (1996). J Virol 70: 1433-1438.
49. May M, Dong XP, Beyer-Finkler E, Stubenrauch F, Fuchs PG, Pfister H. (1994). EMBO J 13: 1460-1466.
50. McNeil S, Guo B, Stein JL, Lian JB, Bushmeyer S, Seto E et al. (1998). J Cell Biochem 68: 500-510.
51. Morgan MJ, Woltering JM, In der Rieden PM, Durston AJ, Thiery JP. (2004). J Biol Chem 279: 46826-46834.
52. Nayak BK, Das BR. (1999). Mol Biol Rep 26: 223-230.
53. Nayak BK, Das GM. (2002). Oncogene 21: 7226-7229.
54. Nguyen N, Zhang X, Olashaw N, Seto E. (2004). J Biol Chem 279: 25927-25934.
55. Oei SL, Shi Y. (2001a). Biochem Biophys Res Commun 285: 27-31.
56. Oei SL, Shi Y. (2001b). Biochem Biophys Res Commun 284: 450-454.
57. Osborne A, Zhang H, Yang WM, Seto E, Blanck G. (2001). Mol Cell Biol 21: 6495-6506.
58. Ossina NK, Cannas A, Powers VC, Fitzpatrick PA, Knight JD, Gilbert JR et al. (1997). J Biol Chem 272: 16351-16357.
59. Palko L, Bass HW, Beyrouthy MJ, Hurt MM. (2004). J Cell Sci 117: 465-476.
60. Parija T, Das BR. (2003). Mol Biol Rep 30: 41-46.
61. Park K, Atchison ML. (1991). Proc Natl Acad Sci USA 88: 9804-9808.
62. Patten M, Wang W, Aminololama-Shakeri S, Burson M, Long CS. (2000). J Mol Cell Cardiol 32: 1341-1352.
63. Petkova V, Romanowski MJ, Sulijoadikusumo I, Rohne D, Kang P, Shenk T et al. (2001). J Biol Chem 276: 7932-7936.
64. Pilarsky C, Wenzig M, Specht T, Saeger HD, Grutzmann R. (2004). Neoplasia 6: 744-750.
65. Pisaneschi G, Ceccotti S, Falchetti ML, Fiumicino S, Carnevali F, Beccari E. (1994). Biochem Biophys Res Commun 205: 1236-1242.
66. Rahman KW, Sarkar FH. (2005). Cancer Res 65: 364-371.
67. Raught B, Khursheed B, Kazansky A, Rosen J. (1994). Mol Cell Biol 14: 1752-1763.
68. Reed JC. (2004). Oncology (Williston Park) 18: 11-20.
69. Riggs KJ, Saleque S, Wong KK, Merrell KT, Lee JS, Shi Y et al. (1993). Mol Cell Biol 13: 7487-7495.
70. Sagoo P, Chan G, Larkin DF, George AJ. (2004). Invest Ophthalmol Vis Sci 45: 3964-3973.
71. Satyamoorthy K, Park K, Atchison ML, Howe CC. (1993). Mol Cell Biol 13: 6621-6628.
72. Seligson D, Horvath S, Huerta-Yepez S, Hanna S, Garban H, Roberts A et al. (2005). Int J Oncol 27: 131-141.
73. Sepulveda MA, Emelyanov AV, Birshtein BK. (2004). J Immunol 172: 1054-1064.
74. Shi Y, Lee JS, Galvin KM. (1997). Biochim Biophys Acta 1332: F49-F66.
75. Shi Y, Seto E, Chang LS, Shenk T. (1991). Cell 67: 377-388.
76. Shrivastava A, Yu J, Artandi S, Calame K. (1996). Proc Natl Acad Sci USA 93: 10638-10641.
77. Sitwala KV, Adams K, Markovitz DM. (2002). Oncogene 21: 8862-8870.
78. Sui G, Affar el B, Shi Y, Brignone C, Wall NR, Yin P et al. (2004). Cell 117: 859-872.
79. Sweetser MT, Hoey T, Sun YL, Weaver WM, Price GA, Wilson CB. (1998). J Biol Chem 273: 34775-34783.
80. Thomas MJ, Seto E. (1999). Gene 236: 197-208.
81. Vega M, Huerta-Yepez S, Jazirehi A, Garban H, Bonavida B. (2005a). Oncogene [Epub ahead of print].
82. Vega M, Jazirehi A, Huerta-Yepez S, Bonavida B. (2005b). J Immunol 175: 2174-2183.
83. Walowitz JL, Bradley ME, Chen S, Lee T. (1998). J Biol Chem 273: 6656-6661.
84. Wang CY, Liang YJ, Lin YS, Shih HM, Jou YS, Yu WC. (2004). J Biol Chem 279: 17750-17755.
85. Wang HG, Rikitake Y, Carter MC, Yaciuk P, Abraham SE, Zerler B et al. (1993). J Virol 67: 476-488.
86. Wang ZX, Wang HY, Wu MC. (2001). Br J Cancer 85: 1162-1167.
87. Weill L, Shestakova E, Bonnefoy E. (2003). J Virol 77: 2903-2914.
88. Wieschaus E, Nusslein-Volhard C, Kluding H. (1984). Dev Biol 104: 172-186.
89. Wolf BB, Green DR. (2002). Curr Biol 12: R177-R179.
90. Yakovleva T, Kolesnikova L, Vukojevic V, Gileva I, Tan-No K, Austen M et al. (2004). Biochem Biophys Res Commun 318: 615-624.
91. Yang WM, Inouye C, Zeng Y, Bearss D, Seto E. (1996). Proc Natl Acad Sci USA 93: 12845-12850.
92. Yao YL, Dupont BR, Ghosh S, Fang Y, Leach RJ, Seto E. (1998). Nucleic Acids Res 26: 3776-3783.
93. Ye J, Ghosh P, Cippitelli M, Subleski J, Hardy KJ, Ortaldo JR et al. (1994). J Biol Chem 269: 25728-25734.
94. Yengi L, Inskip A, Gilford J, Alldersea J, Bailey L, Smith A et al. (1996). Cancer Res 56: 1974-1977.
95. Zhao RY, Elder RT. (2005). Cell Res 15: 143-149.